Test 10.25.25

The chart shows the growth of an initial investment of $10,000 in Test 10.25.25, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.

As of Apr 3, 2026, the Test 10.25.25 returned 17.34% Year-To-Date and 54.07% of annualized return in the last 10 years.

Based on dividend-adjusted daily data since Jun 28, 2010, Test 10.25.25's average daily return is +0.14%, while the average monthly return is +2.96%. At this rate, your investment would double in approximately 2.0 years.

Historically, 59% of months were positive and 41% were negative. The best month was Nov 2015 with a return of +38.3%, while the worst month was Apr 2022 at -18.6%. The longest winning streak lasted 10 consecutive months, and the longest losing streak was 6 months.

On a daily basis, Test 10.25.25 closed higher 53% of trading days. The best single day was Jul 1, 2014 with a return of +14.6%, while the worst single day was Nov 27, 2017 at -12.0%.

Test 10.25.25 has an annualized alpha of 22.90%, beta of 1.13, and R² of 0.34 versus S&P 500 Index. Calculated based on daily prices since June 28, 2010.

• This portfolio captured 202.34% of S&P 500 Index gains and 103.34% of its losses — amplifying both gains and losses, but participating more in upside than downside.
• R² of 0.34 means the benchmark explains less than half of this portfolio's behavior — treat beta with caution or consider switching to a more representative benchmark.

Test 10.25.25 has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

Test 10.25.25 ranks 92 for risk / return — in the top 92% of portfolios on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Test 10.25.25 Sharpe ratios as of Apr 3, 2026 (values are recalculated daily):

• 1-Year: 3.17
• 5-Year: 1.45
• 10-Year: 1.58
• All Time: 1.05

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 0.98 to 1.67, this portfolio's current Sharpe ratio is in the top 25%. This signifies superior risk-adjusted performance, meaning the portfolio is delivering strong returns for the level of risk taken compared to most others.

The chart below shows the rolling Sharpe ratio of Test 10.25.25 compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

Test 10.25.25 provided a 0.07% dividend yield over the last twelve months.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Test 10.25.25. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Test 10.25.25 was 65.06%, occurring on Sep 29, 2015. Recovery took 295 trading sessions.

The current Test 10.25.25 drawdown is 16.68%.

The chart below shows the rolling one-month volatility.